アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/13 | 1,786.5 | 1,797 | 1,778 | 1,788.5 | -6.5 | -0.4% | 3,959,200 |
2021/08/12 | 1,806.5 | 1,822 | 1,793.5 | 1,795 | -8 | -0.4% | 2,986,000 |
2021/08/11 | 1,804 | 1,836.5 | 1,801 | 1,803 | +6 | +0.3% | 4,019,300 |
2021/08/10 | 1,793.5 | 1,821 | 1,788 | 1,797 | +12 | +0.7% | 4,174,600 |
2021/08/06 | 1,776 | 1,801 | 1,771 | 1,785 | -5 | -0.3% | 2,432,200 |
2021/08/05 | 1,784 | 1,806 | 1,782 | 1,790 | -4 | -0.2% | 2,693,500 |
2021/08/04 | 1,803.5 | 1,813 | 1,780 | 1,794 | -1 | -0.1% | 3,079,900 |
2021/08/03 | 1,789 | 1,821.5 | 1,775 | 1,795 | -34 | -1.9% | 7,091,100 |
2021/08/02 | 1,756 | 1,845 | 1,750 | 1,829 | +90 | +5.2% | 7,822,600 |
2021/07/30 | 1,859.5 | 1,863.5 | 1,739 | 1,739 | -168 | -8.8% | 8,885,000 |
2021/07/29 | 1,927 | 1,935 | 1,901.5 | 1,907 | +2 | +0.1% | 2,624,300 |
2021/07/28 | 1,905 | 1,920 | 1,900.5 | 1,905 | -7 | -0.4% | 2,551,200 |
2021/07/27 | 1,921 | 1,924.5 | 1,907 | 1,912 | -9.5 | -0.5% | 2,467,300 |
2021/07/26 | 1,942.5 | 1,945 | 1,908.5 | 1,921.5 | +9.5 | +0.5% | 4,027,000 |
2021/07/21 | 1,943.5 | 1,947 | 1,907.5 | 1,912 | +7 | +0.4% | 3,009,100 |
2021/07/20 | 1,907 | 1,917 | 1,893.5 | 1,905 | -5 | -0.3% | 3,267,100 |
2021/07/19 | 1,903.5 | 1,912 | 1,887 | 1,910 | +5 | +0.3% | 2,947,500 |
2021/07/16 | 1,905 | 1,920.5 | 1,890.5 | 1,905 | -19 | -1% | 3,568,300 |
2021/07/15 | 1,932 | 1,942 | 1,917 | 1,924 | -8 | -0.4% | 4,112,900 |
2021/07/14 | 1,920 | 1,945 | 1,916.5 | 1,932 | +10 | +0.5% | 4,892,700 |
2021/07/13 | 1,928.5 | 1,931.5 | 1,903.5 | 1,922 | +3.5 | +0.2% | 3,942,100 |
2021/07/12 | 1,950 | 1,954.5 | 1,898.5 | 1,918.5 | +47.5 | +2.5% | 3,869,100 |
2021/07/09 | 1,873 | 1,878 | 1,835 | 1,871 | +5.5 | +0.3% | 6,334,800 |
2021/07/08 | 1,880 | 1,886.5 | 1,862.5 | 1,865.5 | -21.5 | -1.1% | 4,815,700 |
2021/07/07 | 1,897 | 1,898 | 1,868 | 1,887 | -17.5 | -0.9% | 5,008,300 |
2021/07/06 | 1,928 | 1,931.5 | 1,897 | 1,904.5 | -16.5 | -0.9% | 2,879,400 |
2021/07/05 | 1,942 | 1,952 | 1,917.5 | 1,921 | -3 | -0.2% | 2,368,500 |
2021/07/02 | 1,917 | 1,946.5 | 1,917 | 1,924 | +7.5 | +0.4% | 4,104,800 |
2021/07/01 | 1,933 | 1,935 | 1,904.5 | 1,916.5 | -18 | -0.9% | 4,529,000 |
2021/06/30 | 1,941 | 1,946 | 1,920 | 1,934.5 | -46.5 | -2.3% | 5,634,700 |
2021/06/29 | 2,000 | 2,004.5 | 1,971 | 1,981 | -29.5 | -1.5% | 4,093,900 |
2021/06/28 | 2,017.5 | 2,025 | 1,996.5 | 2,010.5 | +1 | ±0% | 3,328,200 |
2021/06/25 | 1,998 | 2,017.5 | 1,990.5 | 2,009.5 | +32 | +1.6% | 3,721,000 |
2021/06/24 | 1,978 | 1,991 | 1,969 | 1,977.5 | -11.5 | -0.6% | 2,658,700 |
2021/06/23 | 1,983 | 2,018.5 | 1,972.5 | 1,989 | -2 | -0.1% | 4,937,000 |
2021/06/22 | 1,968 | 1,993 | 1,946.5 | 1,991 | +87 | +4.6% | 6,882,100 |
2021/06/21 | 1,910 | 1,913.5 | 1,883 | 1,904 | -39 | -2% | 5,324,500 |
2021/06/18 | 1,945.5 | 1,971 | 1,934 | 1,943 | +3.5 | +0.2% | 6,237,000 |
2021/06/17 | 1,943.5 | 1,949.5 | 1,924 | 1,939.5 | -12 | -0.6% | 3,027,200 |
2021/06/16 | 1,949.5 | 1,958 | 1,943 | 1,951.5 | +7 | +0.4% | 3,399,900 |
2021/06/15 | 1,918 | 1,944.5 | 1,911 | 1,944.5 | +33 | +1.7% | 4,185,800 |
2021/06/14 | 1,910.5 | 1,927.5 | 1,904 | 1,911.5 | -17 | -0.9% | 3,812,300 |
2021/06/11 | 1,911.5 | 1,949 | 1,910 | 1,928.5 | +19 | +1% | 7,759,900 |
2021/06/10 | 1,920 | 1,924 | 1,904 | 1,909.5 | +9 | +0.5% | 4,309,700 |
2021/06/09 | 1,913 | 1,930 | 1,895.5 | 1,900.5 | -4.5 | -0.2% | 3,888,100 |
2021/06/08 | 1,904.5 | 1,929.5 | 1,896.5 | 1,905 | +15 | +0.8% | 4,073,900 |
2021/06/07 | 1,901.5 | 1,913 | 1,879 | 1,890 | +2 | +0.1% | 3,509,200 |
2021/06/04 | 1,885 | 1,897 | 1,870.5 | 1,888 | -4.5 | -0.2% | 3,900,800 |
2021/06/03 | 1,870 | 1,893 | 1,866 | 1,892.5 | +42.5 | +2.3% | 5,403,300 |
2021/06/02 | 1,850 | 1,856 | 1,810 | 1,850 | +56.5 | +3.2% | 7,771,200 |
851~
900
件表示中 / 3632件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 147,100円 | +18.5% | -96.0% | 5.03% | 188.11倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 412,000円 | +7.7% | +206.9% | 4.76% | 55.34倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 800,700円 | +14.4% | +120.8% | 1.50% | 17.92倍 | 1.64倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 215,300円 | +5.7% | +3.9% | 2.66% | 10.71倍 | 1.42倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 442,400円 | +1.7% | -2.9% | 3.62% | 29.03倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム